FRESEN.MED.CARE KGAA O.N.
FRESEN.MED.CARE KGAA O.N./ DE0005785802 /
FME
|
17/05/2024 17:35:06
|
Diferencia
-1.260
|
Volumen |
Bid17/05/2024 |
Ask17:37:09 |
Capitalización de mecado |
Dividendo A. |
P/E Ratio |
|
40.460EUR
|
-3.02%
|
439,279
Volumen de negocios: 17.76 millones |
-Volumen de oferta: - |
-Tamaño/ Volumen/ Formato de Ask: - |
11.9 mil millonesEUR |
2.93% |
23.85 |
Descripción de negocio
Fresenius Medical Care is the world’s leading provider of products and services for people with chronic kidney failure. Around 2.8 M patients with this disease worldwide regularly undergo dialysis treatment. Dialysis is a vital blood cleansing procedure that substitutes the function of the kidney in case of kidney failure.
Consejo de gestión & Consejo de supervisión
| CEO |
| Helen Giza |
| Consejo de gestión |
| Martin Fischer, Dr. Katarzyna Mazur-Hofsäß, Frank Maddux, MD, Craig Cordola |
| Consejo de supervisión |
| Michael Sen, Stefanie Balling, Sara Hennicken, Shervin J. Korangy, Dr. Marcus Kuhnert, Gregory Sorensen, M.D., Pascale Witz, Ralf Erkens, Beate Haßdenteufel, Regina Karsch, Frank Michael Prescher, Dr. Manuela Stauss-Grabo |
Datos de la empresa
| Nombre: |
Fresenius Medical Care AG & Co. KGaA |
| Dirección: |
Else-Kröner-Straße 1,D-61352 Bad Homburg |
| Teléfono: |
+49-6172-609-0 |
| Fax: |
+49-6172-609-2301 |
| E-mail: |
-
|
| Internet: |
www.fmc-ag.de |
| Industria: |
Healthcare |
| Sector: |
Medical Products |
| Subsector: |
Advanced Medical Devices |
| Fin del año financiero: |
31/12 |
| Acciones de libre circulación: |
44.95% |
| Fecha de OPI: |
02/10/1996 |
Relación con inversores
| Nombre: |
Dr. Dominic Heger |
| IR teléfono: |
+49 (0) 6172 609-2525 |
| IR-fax: |
+49 (0) 6172 609-2301 |
| IR e-mail: |
ir@fmc-ag.com
|
Calendario de la empresa
|
CW 21 | 20/05/2024
Record Date
|
|
CW 21 | 22/05/2024
Dividend Payment
|
|
CW 31 | 30/07/2024
Interim Report 2nd Quarter/6 Months
|
|
CW 45 | 05/11/2024
Interim Report 3rd Quarter/9 Months
|
